SECURITIES AND EXCHANGE COMMISSION
                                   WASHINGTON, D.C.

     Litigation Release No. 15422 / July 25, 1997

     Securities and Exchange Commission v. BioCoral Inc.
     Civil No. 97-CV-101676 (D.D.C.) (filed July 25, 1997)

          On July 25, 1997, the Commission filed a complaint in the United
     States District Court for the District of Columbia against BioCoral, Inc.
     ("BioCoral").  The complaint alleges that BioCoral, a medical products
     company, failed to make available to the investing public current and
     accurate information about its financial condition and results of operation
     through the filing of periodic reports with the Commission as required by
     the Securities Exchange Act of 1934 ("Exchange Act").  Specifically, the
     complaint alleges that BioCoral has not filed its Annual Report on Form 10-
     K for the fiscal year December 31, 1996, two Quarterly Reports on Form 10-Q
     for the fiscal quarters ended March 31, 1997 and September 30, 1996, and
     five Notifications of Late Filing with respect to its delinquent reports. 
     The Commission seeks to compel BioCoral to file its delinquent periodic
     reports and enjoin BioCoral from further violations of Section 13(a) of the
     Exchange Act of 1934 and Rules 12b-25, 13a-1 and 13a-13 thereunder. 
     Simultaneously with the filing of the Commission's complaint, BioCoral
     consented to the entry of a Final Judgment granting the relief sought by
     the Commission and admitted that it had not filed the periodic reports as
     described above.  

























                              ======END OF PAGE 1======